CX3C motif chemokine receptor 1

CX3CR1
Identifiers
AliasesCX3CR1, CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28, C-X3-C motif chemokine receptor 1
External IDsOMIM: 601470; MGI: 1333815; HomoloGene: 20350; GeneCards: CX3CR1; OMA:CX3CR1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001337
NM_001171171
NM_001171172
NM_001171174

NM_009987

RefSeq (protein)

NP_001164642
NP_001164643
NP_001164645
NP_001328

NP_034117

Location (UCSC)Chr 3: 39.26 – 39.28 MbChr 9: 119.73 – 119.9 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

CX3C motif chemokine receptor 1 (CX3CR1), also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein of the G protein-coupled receptor 1 (GPCR1) family and the only known member of the CX3C chemokine receptor subfamily.[5][6][7]

As the name suggests, this receptor binds the inflammatory chemokine CX3CL1 (also called neurotactin in mice or fractalkine in humans). This endogenous ligand solely binds to CX3CR1 receptor. Interaction of CX3CR1 with CX3CL1 can mediate migration, adhesion and retention of leukocytes, because Fractalkine exists as membrane-anchored protein (mCX3CL1) as well as cleaved soluble molecule (sCX3CL1) due to proteolysis by metalloproteinases (MPPs). The shedded form carries out typical function of conventional chemokines, the chemotaxis, while the membrane-bound protein behaves as adhesion molecule for facilitation of diapedesis.[7][8]

Both partners of CX3CL1-CX3CR1 axis are present on numerous cell types from hematopoietic and nonhematopoietic cells throughout the body. Moreover, their distinct cell expression is dependent on specific tissues and organs, which provides broad sphere of biological activity. Hence, considering their various functional activity, they are also linked with multiple neurodegenerative and inflammatory disorders as well as with tumorigenesis.[7][8][9]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000168329Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000052336Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Combadiere C, Ahuja SK, Murphy PM (August 1995). "Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene". DNA and Cell Biology. 14 (8): 673–680. doi:10.1089/dna.1995.14.673. PMID 7646814.
  6. ^ Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM (September 1998). "Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1". The Journal of Biological Chemistry. 273 (37): 23799–23804. doi:10.1074/jbc.273.37.23799. PMID 9726990.
  7. ^ a b c Ferretti E, Pistoia V, Corcione A (2014). "Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies". Mediators of Inflammation. 2014: 480941. doi:10.1155/2014/480941. PMC 3985314. PMID 24799766.
  8. ^ a b Wojdasiewicz P, Turczyn P, Dobies-Krzesniak B, Frasunska J, Tarnacka B (2019-11-12). "Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis". Mediators of Inflammation. 2019: 7570452. doi:10.1155/2019/7570452. PMC 6875359. PMID 31780870.
  9. ^ Lee M, Lee Y, Song J, Lee J, Chang SY (February 2018). "Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease". Immune Network. 18 (1): e5. doi:10.4110/in.2018.18.e5. PMC 5833124. PMID 29503738.